CA2921187A1 - Method for enhancing tumor growth - Google Patents

Method for enhancing tumor growth Download PDF

Info

Publication number
CA2921187A1
CA2921187A1 CA2921187A CA2921187A CA2921187A1 CA 2921187 A1 CA2921187 A1 CA 2921187A1 CA 2921187 A CA2921187 A CA 2921187A CA 2921187 A CA2921187 A CA 2921187A CA 2921187 A1 CA2921187 A1 CA 2921187A1
Authority
CA
Canada
Prior art keywords
cells
human
mammal
stem cells
nme7
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA2921187A
Other languages
English (en)
French (fr)
Inventor
Cynthia C. Bamdad
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Minerva Biotechnologies Corp
Original Assignee
Minerva Biotechnologies Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2014/017515 external-priority patent/WO2014130741A2/en
Application filed by Minerva Biotechnologies Corp filed Critical Minerva Biotechnologies Corp
Publication of CA2921187A1 publication Critical patent/CA2921187A1/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • A61K49/0008—Screening agents using (non-human) animal models or transgenic animal models or chimeric hosts, e.g. Alzheimer disease animal model, transgenic model for heart failure
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0271—Chimeric vertebrates, e.g. comprising exogenous cells
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2207/00—Modified animals
    • A01K2207/12—Animals modified by administration of exogenous cells
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2207/00—Modified animals
    • A01K2207/15—Humanized animals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/105—Murine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A01K2267/0331—Animal model for proliferative diseases

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pathology (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Endocrinology (AREA)
  • Cell Biology (AREA)
  • Animal Husbandry (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Compounds Of Unknown Constitution (AREA)
CA2921187A 2013-08-12 2014-08-12 Method for enhancing tumor growth Pending CA2921187A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201361865092P 2013-08-12 2013-08-12
US61/865,092 2013-08-12
PCT/US2014/017515 WO2014130741A2 (en) 2013-02-20 2014-02-20 Nme inhibitors and methods of using nme inhibitors
USPCT/US14/17515 2014-02-20
PCT/US2014/050773 WO2015023694A2 (en) 2013-08-12 2014-08-12 Method for enhancing tumor growth

Publications (1)

Publication Number Publication Date
CA2921187A1 true CA2921187A1 (en) 2015-02-19

Family

ID=52468797

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2921187A Pending CA2921187A1 (en) 2013-08-12 2014-08-12 Method for enhancing tumor growth

Country Status (8)

Country Link
EP (2) EP3038462B1 (enExample)
JP (2) JP6640086B2 (enExample)
CN (1) CN105764334B (enExample)
AU (2) AU2014306778B2 (enExample)
CA (1) CA2921187A1 (enExample)
IL (1) IL244093B (enExample)
TW (1) TWI659210B (enExample)
WO (1) WO2015023694A2 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108513537A (zh) * 2015-09-23 2018-09-07 米纳瓦生物技术公司 筛选分化干细胞的试剂的方法
WO2018183654A1 (en) * 2017-03-29 2018-10-04 Minerva Biotechnologies Corporation Agents for differentiating stem cells and treating cancer
CN108434452A (zh) * 2018-03-13 2018-08-24 安徽瀚海博兴生物技术有限公司 一种将pd-1抗体和jmjd6联合用于制备抗癌药物的应用
CN116075318A (zh) 2020-06-26 2023-05-05 米纳瓦生物技术公司 抗nme抗体及治疗癌症或癌症转移的方法
WO2023201234A2 (en) 2022-04-12 2023-10-19 Minerva Biotechnologies Corporation Anti-variable muc1* antibodies and uses thereof
WO2025049494A1 (en) 2023-08-29 2025-03-06 Minerva Biotechnologies Corporation Bacterial nme7 orthologs and uses thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8562988B2 (en) * 2005-10-19 2013-10-22 Ibc Pharmaceuticals, Inc. Strategies for improved cancer vaccines
US20090214483A1 (en) * 2005-06-30 2009-08-27 Weinberg Robert A Progenitor Cells and Uses Thereof
MX2008015492A (es) * 2006-06-06 2009-02-12 Univ Tennessee Res Foundation Composiciones enriquecidas en celulas madre neoplasicas y metodos que las contienen.
CN101855339A (zh) * 2007-01-22 2010-10-06 雷文生物技术公司 人类癌症干细胞
KR20140101876A (ko) * 2008-10-09 2014-08-20 미네르바 바이오테크놀로지 코포레이션 세포내에서 다능성을 유도하기 위한 방법
EP4086338A1 (en) * 2011-03-17 2022-11-09 Minerva Biotechnologies Corporation Method for making pluripotent stem cells
WO2012165287A1 (ja) * 2011-05-27 2012-12-06 公立大学法人横浜市立大学 人工癌幹細胞の作製方法及びその分化誘導方法
WO2013059373A2 (en) * 2011-10-17 2013-04-25 Minerva Biotechnologies Corporation Media for stem cell proliferation and induction
EP2749642A4 (en) * 2011-11-30 2015-03-04 Nat Cancer Ct INDUCED MALIGNE STEM CELLS
CA2880010A1 (en) * 2012-07-24 2014-01-30 Minerva Biotechnologies Corporation Nme variant species expression and suppression
KR20210082547A (ko) * 2013-02-20 2021-07-05 미네르바 바이오테크놀로지 코포레이션 Ｎｍｅ 저해제 및 ｎｍｅ 저해제의 사용 방법

Also Published As

Publication number Publication date
EP4233536A3 (en) 2023-10-25
AU2021200429B2 (en) 2023-05-11
IL244093A0 (en) 2016-04-21
AU2021200429A1 (en) 2021-02-25
EP3038462B1 (en) 2023-03-15
JP6640086B2 (ja) 2020-02-05
AU2014306778B2 (en) 2020-10-29
TWI659210B (zh) 2019-05-11
AU2014306778A1 (en) 2016-03-03
JP6902577B2 (ja) 2021-07-14
IL244093B (en) 2022-01-01
JP2019213551A (ja) 2019-12-19
EP3038462A4 (en) 2017-06-14
WO2015023694A2 (en) 2015-02-19
JP2016527901A (ja) 2016-09-15
CN105764334A (zh) 2016-07-13
TW201537172A (zh) 2015-10-01
EP3038462A2 (en) 2016-07-06
CN105764334B (zh) 2020-07-28
WO2015023694A3 (en) 2015-04-23
EP4233536A2 (en) 2023-08-30
AU2021200429C1 (en) 2023-11-30

Similar Documents

Publication Publication Date Title
US20220193270A1 (en) Method for enhancing tumor growth
AU2021200429C1 (en) Method for enhancing tumor growth
JP6602745B2 (ja) 非胚性幹細胞の単離とその使用
JP2017525351A (ja) 多能性幹細胞の培養用培地
KR102116794B1 (ko) 분화다능성 줄기세포의 제조방법
CN109456932A (zh) 用于干细胞增殖和诱导的培养基
JP7307481B2 (ja) 始原生殖細胞／始原生殖細胞様細胞の維持増幅及び分化誘導方法
US20180258186A1 (en) NME Inhibitors and Methods of Using NME Inhibitors
JP2021522819A (ja) インビトロベータ細胞分化に関連する細胞集団および遺伝子発現
Dementyeva et al. Applying patient-specific induced pluripotent stem cells to create a model of hypertrophic cardiomyopathy
AU2016287603A1 (en) Method of stem cell-based organ and tissue generation
CN102816739B (zh) c-Jun的截短型维持胚胎干细胞多能性的方法和应用
Abdelhay et al. Networks Establishing Hematopoietic Stem Cell Multipotency and Self-Renewal

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20171229

EEER Examination request

Effective date: 20171229

EEER Examination request

Effective date: 20171229

EEER Examination request

Effective date: 20171229

EEER Examination request

Effective date: 20171229

EEER Examination request

Effective date: 20171229

EEER Examination request

Effective date: 20171229

EEER Examination request

Effective date: 20171229